This press release was provided by Select Biosciences.
Select Biosciences South East Asia is pleased to present Advances in qPCR and dPCR.
Having successfully run the event in Boston, USA, Frankfurt, Germany, Daejeon, Korea and Barcelona, Spain, we look forward to bringing the meeting to Singapore.
The event will take place on the 21-22 May 2015.
We will be focusing on new developments in qPCR technology, concentrating on improvements to qPCR design, the acquisition of accurate data, and efficient data analysis. Particular emphasis will also be given to the use of qPCR in Cancer diagnosis.
Focus will also be given to the use of dPCR in the clinic, covering applications such as infectious disease diagnostics and cancer detection. Another important area for discussion will be the applications for forensics and anti-terrorism.
Attending this meeting will give you an excellent opportunity for networking with like-minded peers, helping you to find unique solutions and build long term collaborations.
Professor, New Jersey Medical School, Rutgers University, USA
Professor/Founder, TATAA Biocenter, Sweden
- Bioinformatics and Data Analysis
- Clinical Applications of Digital PCR
- Diagnosing Cancer with qPCR
- Forensics and Anti-terrorism Uses
- Mutation Analysis
- New Developments in Digital PCR
- New qPCR Approaches
- PLA – Proximity Ligation Assays
- qPCR in Diagnostics
- Single Cell Analysis
- Standardisation & Validation
Paul Raggett, CEO
Select Biosciences South East Asia Pte. Ltd.
16 Raffles Quay, #33-03 Hong Leong Building, Singapore 048581
Tel: +65 9186 3246
Email: [email protected]